laxoSmithKline was ordered to pay $3 million to the widow of an attorney who committed suicide after taking a generic version of its Paxil antidepressant, because the federal court jury decided the drug maker failed to properly warn about the risk of its medicine.

The five-week trial was closely watched because it turned on a contentious issue — whether consumers can successfully sue a brand-name drug maker if they suffered harm after taking a pill made by a generic rival. In this instance, Stewart Dolin, 57, had taken a generic version of Paxil that was sold by Mylan Pharmaceuticals, which was also named when the lawsuit was originally filed, but was later dismissed.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.